Antibiotic resistance is a threat to the vision to eradicate tuberculosis (TB) by 2035. The…
IT SynapseSeptember 23, 2024
TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the…
Inari SoininenNovember 26, 2021
An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in…
Inari SoininenMarch 26, 2021
Innovative Medicines Initiative Launches European Regimen Accelerator For Tuberculosis (ERA4TB) project.
adminJanuary 29, 2020
